| Trial Outcome | RIPC group | Control group | ‘p’ |
|---|---|---|---|
|
Primary end point Contrast Induced AKI |
6/50(14%) | 19/50(38%) | 0.0055(S) |
| Secondary endpoint | |||
| S. creatinine at Day 0 (mg/dl) | 1.32 +/- 0.3 | 1.31 +/- 0.28 | 0.7828 (NS) |
| Day 1 | 1.43 +/- 0.35 | 1.48 +/- 0.4 | 0.4776 (NS) |
| Day 2 | 1.32 ± 0.41 | 1.49 ± 0.56 | 0.0879 (NS) |
| Change in creatinine(mg/dl) | -0.002 ± 0.27 | 0.184 ± 0.429 | 0.0104 (S) |
| % of Change | -0.06 ± 21.36 | 13.01 ± 30.29 | 0.0143 (S) |
| CI-AKI in CKD 3a Hemodialysis |
10% 0(0%) |
32% 4(8%) |
0.004 (S) 0.0587(NS) |
| Hospital stay (days) | 5.06 +/- 1.43 | 5.12 +/- 1.56 | 0.8418(NS) |
| Mortality | 0(0%) | 1(2%) | 0.5 (NS) |
| Rehospitalisation | 1(2%) | 8(16%) | 0.0154 (S) |